/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Regeneration.VC
Redondo BeachPre-Seed–Series B$1M – $3M
10 people
Shoreline Venture Management
Bay AreaSeed–Series A$250K – $8M
13 people
Health2047
San FranciscoSeed
21 people
HealthQuest Capital
Redwood CityGrowth–Late Stage
12 people
One Planet Capital
CambridgePre-Seed–Seed$25K – $500K
6 people
Trinity Capital
PhoenixGrowth
18 people
BioHealth Innovation, Inc.
Rockville
23 people
Innospark Ventures
BostonPre-Seed–Series A$2M
11 people
Starship Ventures
San FranciscoPre-Seed–Seed
14 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
11 people
Foresite Labs
San FranciscoPre-Seed
25 people
REMUS Capital
BostonPre-Seed–Series B$25K – $20M
9 people
Divergent Capital
New YorkPre-Seed–Seed$250K – $1M
8 people
New North Ventures
PortsmouthPre-Seed–Series A$1M
14 people
Axial VC
San FranciscoPre-Seed–Seed$100K – $5M
2 people
Mountain Group Capital
NashvillePre-Seed–Seed
13 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
16 people
Verdex Capital
CalgarySeed–Series A
10 people
Carbon Direct
New York
21 people
Iaso Ventures
CambridgeSeed–Series A
15 people
Wireframe Ventures
San FranciscoPre-Seed–Seed$500K – $2M
3 people
Toronto Innovation Acceleration Partners
TorontoPre-Seed–Seed
11 people
IU Ventures
BloomingtonSeed–Series A
1 person
WMU Biosciences Research & Commercialization Center
KalamazooSeed–Series A$100K – $250K
12 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.